Latest filing published 16 Nov 2015 for ReShape Lifesciences Inc., €46k.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Mark B. Knudson is a declared insider at 2 companies; the most frequent names are ReShape Lifesciences Inc. and Restore Medical, Inc. Between 22 May 2006 and 12 November 2015, the trades on record add up to 17 filings.
Every open-market trade on record is a purchase: 7 purchases worth €206k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2015 to date brings 3 purchases and no sales.
In size, the median ticket on the buying side is €33k.
Most recently, on 16 November 2015, the filings show an open-market purchase worth €46k in ReShape Lifesciences Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations